AVITA Medical Inc (RCEL)
8.63
-0.24
(-2.71%)
USD |
NASDAQ |
Apr 19, 16:00
8.63
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Cash from Financing (TTM): 40.37M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 40.37M |
September 30, 2023 | 1.841M |
June 30, 2023 | 1.241M |
March 31, 2023 | 1.07M |
December 31, 2022 | 0.90M |
September 30, 2022 | 0.004M |
June 30, 2022 | 0.035M |
Date | Value |
---|---|
March 31, 2022 | 64.06M |
September 30, 2021 | 64.06M |
June 30, 2021 | 64.05M |
March 31, 2021 | 64.17M |
December 31, 2020 | 0.208M |
September 30, 2020 | 77.07M |
June 30, 2020 | 77.06M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.004M
Minimum
Sep 2022
77.07M
Maximum
Sep 2020
32.58M
Average
21.11M
Median
Cash from Financing (TTM) Benchmarks
Cerus Corp | 10.67M |
Elutia Inc | 9.84M |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |